the news highlighted another factor in the chinese threat: regardless of the different regulatory framework, many researchers think the data they report is valid..

erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the... january 2010  (17).